Health-related quality of life outcomes in patients with myelodysplastic syndromes with ring sideroblasts treated with luspatercept in the MEDALIST phase 3 trial
- Esther Natalie Oliva*
- , Uwe Platzbecker
- , Guillermo Garcia-Manero
- , Ghulam J. Mufti
- , Valeria Santini
- , Mikkael A. Sekeres
- , Rami S. Komrokji
- , Jeevan K. Shetty
- , Derek Tang
- , Shien Guo
- , Weiqin Liao
- , George Zhang
- , Xianwei Ha
- , Rodrigo Ito
- , Jennifer Lord-Bessen
- , Jay T. Backstrom
- , Pierre Fenaux
*Corresponding author for this work
- Grande Ospedale Metropolitano Bianchi Melacrino Morelli
- University Hospital Leipzig
- University of Texas M. D. Anderson Cancer Center
- Careggi Hospital
- University of Miami, Sylvester Comprehensive Cancer Center
- H. Lee Moffitt Cancer Center and Research Institute
- Bristol-Myers Squibb International Corporation
- Evidera, USA
- Acceleron Pharma
- University of Paris VII - Denis Diderot University
Research output: Contribution to journal › Article › peer-review
20
Citations
(Scopus)